In luminal B HER2+ breast cancer, miR-210, miR-4516, miR-718, and miR-125b-5p were specifically associated with chemo-sensitivity [145] and high levels of miR-125b-5p during neoadjuvant chemotherapy [NAC] treatment predicted a poor disease free survival [DFS] [146]. Here, ERBB2 is linked to breast carcinoma.